BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6129492)

  • 1. Uterine rupture due to 15-methylprostaglandin F2 alpha.
    Vergote I; Oeyen L; De Schrijver D; Uyttenbroeck F
    Lancet; 1982 Dec; 2(8312):1402. PubMed ID: 6129492
    [No Abstract]   [Full Text] [Related]  

  • 2. Uterine rupture following intramuscular injection of Carboprost in midtrimester pregnancy termination.
    Tripathy SN
    J Indian Med Assoc; 1985 Sep; 83(9):328. PubMed ID: 4086862
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandins, oxytocin, and uterine rupture.
    Cederqvist LL
    Lancet; 1983 Feb; 1(8321):420-1. PubMed ID: 6130412
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Rupture of uterus during prostaglandin-induced abortion.
    Smith AM
    Br Med J; 1975 Jan; 1(5951):205. PubMed ID: 1111746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rupture of the uterus during prostaglandin-induced abortion.
    Jarvis GJ; Johnson DA; Emery S
    Br Med J; 1979 Sep; 2(6191):671. PubMed ID: 497785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of second trimester pregnancy with a long-acting vaginal pessary containing 15-methyl-PGF2 alpha methyl ester.
    Int J Gynaecol Obstet; 1983 Apr; 21(2):159-65. PubMed ID: 6136437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin F2 alpha for interrupting pregnancy, managing intrauterine death and molar pregnancy and inducing labor.
    de Gezelle H; Thiery M; Parewijck W; Decoster JM
    Int J Gynaecol Obstet; 1980; 17(4):362-7. PubMed ID: 6102058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of missed abortion by intramuscular administration of 15(S) 15 methyl prostaglandin F2 alpha.
    Mapa MK; Singh PM; Misra I
    Asia Oceania J Obstet Gynaecol; 1982 Dec; 8(4):369-72. PubMed ID: 7171346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rupture of a healthy uterus in a prostaglandin-induced abortion in the second trimester].
    Larue L; Marpeau L; Percque M; Castiel J; Guettier X; Maghioracos P; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):269-72. PubMed ID: 2071873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins and abortion. III. Comparison of single intra-amniotic injections of 15-methyl prostaglandin F2alpha and prostaglandin F2alpha for termination of second-trimester pregnancy: an international multicenter study. World Health Organization Tast Force on the Use of Prostaglandins forthe Regulation of Fertility.
    Am J Obstet Gynecol; 1977 Nov; 129(6):601-6. PubMed ID: 920761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midtrimester abortion with intravenous administration of 15 methyl prostaglandin F2 alpha.
    Mapa MK; Kochhar U; Raghavan KS; Devi PK
    Int J Gynaecol Obstet; 1982 Apr; 20(2):125-8. PubMed ID: 6125431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rupture of the cervix in prostaglandin abortions.
    Kajanoja P; Jungner G; Widholm O; Karjalainen O; Seppälä M
    J Obstet Gynaecol Br Commonw; 1974 Mar; 81(3):242-4. PubMed ID: 4821484
    [No Abstract]   [Full Text] [Related]  

  • 13. Uterine rupture after intra-amniotic injection of prostaglandin E2.
    Emery S; Jarvis GJ; Johnson DA
    Br Med J; 1979 Jul; 2(6181):51. PubMed ID: 466276
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostaglandins and abortion. I. intramuscular administration of 15-methyl prostaglandin F2alpha for induction of abortion in weeks 10 to 20 of pregnancy. World Health Organization Task Force on the Use of Prostaglandins for the Regulation of Fertility.
    Am J Obstet Gynecol; 1977 Nov; 129(6):593-6. PubMed ID: 920759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine rupture as a complication of second trimester abortion using intraamniotic prostaglandin E2 and augmentation with other oxytocic agents.
    McCarthy T; McQueen J
    Prostaglandins; 1980 Jun; 19(6):849-54. PubMed ID: 7384558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of mid-trimester pregnancy with intramuscular 15-(S)-15-,methyl-prostaglandin F2 alpha.
    Tsalacopoulos G; Bloch B; Rush JM
    S Afr Med J; 1982 May; 61(22):822-4. PubMed ID: 7079902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intramuscular administration of Prostin for abortion in the second trimester].
    Curić F; Vilendecić R
    Jugosl Ginekol Opstet; 1984; 24(3-4):68-70. PubMed ID: 6503343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Termination of pregnancy in the 2nd trimester using intra-amniotic administration of prostaglandins].
    Krofta L; Calda P; Zizka Z; Parízek A; Hrusková H; Kapras J
    Ceska Gynekol; 1998 Oct; 63(5):414-7. PubMed ID: 9818502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of a long-acting vaginal suppository of 15-ME-PGF2 alpha in first and second trimester abortion.
    Lauersen NH; Wilson KH
    Adv Prostaglandin Thromboxane Res; 1980; 8():1435-41. PubMed ID: 7376994
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancy.
    Bygdeman M; Ganguli A; Kinoshita K; Lundström V; Green K; Bergström S
    Contraception; 1977 Feb; 15(2):129-41. PubMed ID: 837687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.